354 related articles for article (PubMed ID: 29081214)
21. Immunogenicity and protective efficacy of multistage vaccine candidates (Mtb8.4-HspX and HspX-Mtb8.4) against Mycobacterium tuberculosis infection in mice.
Liu W; Li J; Niu H; Lin X; Li R; Wang Y; Xin Q; Yu H; Wu Y; Zhu B; Tan J
Int Immunopharmacol; 2017 Dec; 53():83-89. PubMed ID: 29045910
[TBL] [Abstract][Full Text] [Related]
22. Novel lipopeptides of ESAT-6 induce strong protective immunity against Mycobacterium tuberculosis: Routes of immunization and TLR agonists critically impact vaccine's efficacy.
Gupta N; Vedi S; Kunimoto DY; Agrawal B; Kumar R
Vaccine; 2016 Nov; 34(46):5677-5688. PubMed ID: 27693020
[TBL] [Abstract][Full Text] [Related]
23. Ag85b/ESAT6-CFP10 adjuvanted with aluminum/poly-IC effectively protects guinea pigs from latent mycobacterium tuberculosis infection.
Wang C; Lu J; Du W; Wang G; Li X; Shen X; Su C; Yang L; Chen B; Wang J; Xu M
Vaccine; 2019 Jul; 37(32):4477-4484. PubMed ID: 31266673
[TBL] [Abstract][Full Text] [Related]
24. Adenylate kinase: a novel antigen for immunodiagnosis and subunit vaccine against tuberculosis.
Xiao Y; Sha W; Tian Z; Chen Y; Ji P; Sun Q; Wang H; Wang S; Fang Y; Wen HL; Zhao HM; Lu J; Xiao H; Fan XY; Shen H; Wang Y
J Mol Med (Berl); 2016 Jul; 94(7):823-34. PubMed ID: 26903285
[TBL] [Abstract][Full Text] [Related]
25. A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis.
Liu X; Peng J; Hu L; Luo Y; Niu H; Bai C; Wang Q; Li F; Yu H; Wang B; Chen H; Guo M; Zhu B
Hum Vaccin Immunother; 2016 Jul; 12(7):1670-7. PubMed ID: 26901244
[TBL] [Abstract][Full Text] [Related]
26. Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.
Holten-Andersen L; Doherty TM; Korsholm KS; Andersen P
Infect Immun; 2004 Mar; 72(3):1608-17. PubMed ID: 14977968
[TBL] [Abstract][Full Text] [Related]
27. Cell wall skeleton of Mycobacterium bovis BCG enhances the vaccine potential of antigen 85B against tuberculosis by inducing Th1 and Th17 responses.
Back YW; Choi S; Choi HG; Shin KW; Son YJ; Paik TH; Kim HJ
PLoS One; 2019; 14(3):e0213536. PubMed ID: 30849108
[TBL] [Abstract][Full Text] [Related]
28. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
[TBL] [Abstract][Full Text] [Related]
29. Immunological characteristics of Mycobacterium tuberculosis subunit vaccines immunized through different routes.
Lu Y; Kang J; Ning H; Wang L; Xu Y; Xue Y; Xu Z; Wu X; Bai Y
Microb Pathog; 2018 Dec; 125():84-92. PubMed ID: 30195646
[TBL] [Abstract][Full Text] [Related]
30. Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy.
Orr MT; Beebe EA; Hudson TE; Argilla D; Huang PW; Reese VA; Fox CB; Reed SG; Coler RN
Vaccine; 2015 Nov; 33(48):6570-8. PubMed ID: 26541135
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.
Orr MT; Fox CB; Baldwin SL; Sivananthan SJ; Lucas E; Lin S; Phan T; Moon JJ; Vedvick TS; Reed SG; Coler RN
J Control Release; 2013 Nov; 172(1):190-200. PubMed ID: 23933525
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of immune response against Mycobacterium tuberculosis HspX antigen by incorporation of combined molecular adjuvant (CASAC).
Lew MH; Norazmi MN; Tye GJ
Mol Immunol; 2020 Jan; 117():54-64. PubMed ID: 31739193
[TBL] [Abstract][Full Text] [Related]
33. A Promising Listeria-Vectored Vaccine Induces Th1-Type Immune Responses and Confers Protection Against Tuberculosis.
Yin Y; Lian K; Zhao D; Tao C; Chen X; Tan W; Wang X; Xu Z; Hu M; Rao Y; Zhou X; Pan Z; Zhang X; Jiao X
Front Cell Infect Microbiol; 2017; 7():407. PubMed ID: 29034213
[TBL] [Abstract][Full Text] [Related]
34. Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection.
Parlane NA; Compton BJ; Hayman CM; Painter GF; Basaraba RJ; Heiser A; Buddle BM
Vaccine; 2012 Jan; 30(3):580-8. PubMed ID: 22120192
[TBL] [Abstract][Full Text] [Related]
35. Alarmin IL-33 elicits potent TB-specific cell-mediated responses.
Villarreal DO; Siefert RJ; Weiner DB
Hum Vaccin Immunother; 2015; 11(8):1954-60. PubMed ID: 26091147
[TBL] [Abstract][Full Text] [Related]
36. Immunological and physical evaluation of the multistage tuberculosis subunit vaccine candidate H56/CAF01 formulated as a spray-dried powder.
Thakur A; Ingvarsson PT; Schmidt ST; Rose F; Andersen P; Christensen D; Foged C
Vaccine; 2018 May; 36(23):3331-3339. PubMed ID: 29699790
[TBL] [Abstract][Full Text] [Related]
37. Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice.
Xin Q; Niu H; Li Z; Zhang G; Hu L; Wang B; Li J; Yu H; Liu W; Wang Y; Da Z; Li R; Xian Q; Wang Y; Zhang Y; Jing T; Ma X; Zhu B
PLoS One; 2013; 8(8):e72745. PubMed ID: 23967337
[TBL] [Abstract][Full Text] [Related]
38. A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity.
Khademi F; Derakhshan M; Yousefi-Avarvand A; Najafi A; Tafaghodi M
Microb Pathog; 2018 Dec; 125():507-513. PubMed ID: 30352265
[TBL] [Abstract][Full Text] [Related]
39. Oxidized Carbon Nanosphere-Based Subunit Vaccine Delivery System Elicited Robust Th1 and Cytotoxic T Cell Responses.
Sawutdeechaikul P; Cia F; Bancroft G; Wanichwecharungruang S; Sittplangkoon C; Palaga T
J Microbiol Biotechnol; 2019 Mar; 29(3):489-499. PubMed ID: 30691253
[TBL] [Abstract][Full Text] [Related]
40. The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice.
Kao FF; Mahmuda S; Pinto R; Triccas JA; West NP; Britton WJ
PLoS One; 2012; 7(5):e34991. PubMed ID: 22567094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
